Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Angiodynamics Inc 14 PLAZA DRIVE LATHAM NY 12110 USA

P: 518-795-1400 F: 518-795-1401

Description:

AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines.

Key Statistics

Overview:

Market Capitalization, $K 508,742
Enterprise Value, $K 504,912
Shares Outstanding, K 39,134
Annual Sales, $ 316,220 K
Annual Net Income, $ -26,550 K
Last Quarter Sales, $ 85,430 K
Last Quarter Net Income, $ -8,490 K
60-Month Beta 0.66
% of Insider Shareholders 4.90%
% of Institutional Shareholders 94.94%
Float, K 37,216
% Float 95.10%
Short Volume Ratio 0.34

Growth:

1-Year Return -38.07%
3-Year Return -5.59%
5-Year Return -24.64%
5-Year Revenue Growth -9.56%
5-Year Earnings Growth -100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 01/05/23
Next Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 116.67%
EPS Growth vs. Prev Year 150.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ANGO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 1,714.67
Price/Earnings to Growth N/A
Return-on-Equity % -0.14%
Return-on-Assets % -0.10%
Profit Margin % -8.40
Net Margin % 3.81
Debt/Equity 0.12
Price/Sales 1.59
Price/Cash Flow 17.07
Price/Book 1.23
Book Value/Share 10.43
Interest Coverage -42.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar